Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial (Q38464882)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 August 2012
edit
Language Label Description Also known as
English
Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial
scientific article published on 29 August 2012

    Statements

    Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial (English)
    Andrew J Lewin
    Lisa Arvay
    Dacheng Liu
    Sanjay Patel
    Hans-Juergen Woerle
    29 August 2012
    1909-19.e15

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit